StockNews.com assumed coverage on shares of USD Partners (NYSE:USDP – Free Report) in a report issued on Saturday. The firm issued a hold rating on the transportation company’s stock.
USD Partners Price Performance
USDP opened at $0.02 on Friday. USD Partners has a 1 year low of $0.01 and a 1 year high of $0.80. The company has a market capitalization of $506,610.00, a price-to-earnings ratio of 0.07 and a beta of 0.69. The firm’s fifty day moving average price is $0.03 and its two-hundred day moving average price is $0.08.
USD Partners (NYSE:USDP – Get Free Report) last released its quarterly earnings results on Monday, August 12th. The transportation company reported ($0.36) earnings per share for the quarter. The company had revenue of $8.88 million for the quarter.
About USD Partners
USD Partners LP acquires, develops, and operates midstream infrastructure assets and logistics solutions for crude oil, biofuels, and other energy-related products in the United States and Canada. It operates through two segments, Terminalling Services and Fleet Services. The Terminalling Services segment owns and operates Hardisty terminal, an origination terminal for loading various grades of Canadian crude oil onto railcars for transportation to end markets; Stroud terminal, a crude oil destination terminal, which is used to facilitate rail-to-pipeline shipments of crude oil located in Stroud, Oklahoma; Casper terminal, a crude oil storage, blending, and railcar loading terminal located in Casper, Wyoming; and West Colton Terminal, an unit train-capable destination terminals that trans load approximately 13,000 barrels per day ethanol and renewable diesel received by rail from producers onto trucks.
Featured Stories
- Five stocks we like better than USD Partners
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Why Lennar Stock Could Be the Best Play in the Housing Market
- Do ETFs Pay Dividends? What You Need to Know
- 2 Energy Stocks Fueling the AI Datacenter Boom
- How to Invest in the FAANG Stocks
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for USD Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USD Partners and related companies with MarketBeat.com's FREE daily email newsletter.